Pacira | PCRX - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Astellas Pharma JPY 4.1T 160.64B 2026-08
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Cara Therapeutics USD 110M 80M 2026-08
Coherus Biosciences USD 172M 19M 2025-12
Heron Therapeutics USD 238M 7M 2025-12
J&J USD 611.36B 32.21B 2026-06
Ligand Pharmaceuticals USD 5.31B 1.02B 2026-08
Nektar Therapeutics USD 12.98B 10.86B 2026-08
Novo Nordisk A/S DKK 1.03T 373.76B 2026-08
Pacira USD 1.28B 286M 2026-08
Perrigo USD 1.45B 135M 2026-08
Pfizer USD 153.17B 14.73B 2026-08
Supernus Pharmaceuticals USD 2.58B 116M 2026-08
Teva Pharmaceutical Industries USD 114.54B 80.27B 2026-06
Xeris Pharmaceuticals USD 1000M 303M 2026-03
Zoetis USD 35.38B 5.25B 2026-08